Back to Agenda
FDA - Health Canada Regulatory Cooperation Council (RCC) Town Hall
Session Chair(s)
Sema Hashemi, MS
Senior International Policy Advisor, FDA, United States
At the request of stakeholders, FDA and Health Canada will highlight their work and lessons learned under the four Regulatory Cooperation Council (RCC) initiatives on the electronic submission gateway, common monographs for over-the-counter drugs, good manufacturing practices and veterinary drugs. Presentations will be followed by a question and answer period on next steps in the RCC process. Stakeholders are encouraged to express their views and innovative ideas as regulators discuss the future of RCC..
You may submit questions and topics of interest in advance to annualmeetingprogram@diahome.org, and include “RCC Town Hall” in the subject line.
Learning Objective : Identify work and lessons learned under the four Regulatory Cooperation Council (RCC) initiatives on the electronic submission gateway, common monographs for over-the-counter drugs, good manufacturing practices and veterinary drugs.
Speaker(s)
Louise Déry
Director, Policy, Planning and International Affairs Directorate, Health Canada, Canada
Panelist
Sema Hashemi, MS
Senior International Policy Advisor, FDA, United States
Panelist
Have an account?